Tango Therapeutics Inc (TNGX) — Capital Reinvestment Ratio
Tango Therapeutics Inc (TNGX) has a Capital Reinvestment Ratio of 0.00x as of September 2020, meaning it reinvests 0% of its operating cash flow ($111.26 Million) in capital expenditures ($132.00K). See Tango Therapeutics Inc (TNGX) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tango Therapeutics Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Tango Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check TNGX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Tango Therapeutics Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Tango Therapeutics Inc from 2020 to 2020. For live market cap and broader valuation context, see Tango Therapeutics Inc (TNGX) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.02x | $70.07 Million | $1.11 Million | — |